All blog posts
By topic:
If you work in primary care, chances are you’re talking about GLP-1 prescriptions for weight loss multiple times a day. Maybe you're explaining why Wegovy isn’t covered, managing labs and titration schedules, or helping a patient understand why they regained weight after stopping. It's a challenging landscape, and we’re all trying to keep up.
There was a time when prescribing continuous glucose monitors (CGMs) felt like an impossible ask unless your patient had type 1 diabetes or was on multiple daily insulin injections. Between the mountains of prior authorization paperwork and rigid insurance requirements, most of our patients with type 2 diabetes didn’t qualify — even if they were desperate for better data or a clearer picture of their blood sugar trends.
On November 10, 2025, the FDA announced a request to change to the labeling for menopausal hormone therapy (MHT). This was big news, and it has major ramifications for our patients.
It’s been more than a decade, but the Infectious Diseases Society of America (IDSA) has finally released updated guidelinesfor complicated urinary tract infections (cUTIs) — and there’s a lot for clinicians to digest.
If you’ve spent any time examining toddlers with urinary complaints, chances are you’ve encountered pediatric labial adhesions — maybe without realizing it at first. It’s one of the more common yet under-discussed vulvar conditions in children, and the good news is that most of the time, management is simple, gentle, and completely in your wheelhouse.
How to confidently identify true pediatric food allergies, avoid unnecessary testing, and support families with evidence-based care.
Opioid overdoses have become an unavoidable part of our daily shifts in the ED. It is a tragic commonality that transcends social and economic lines. It would be a safe bet that if you are reading this, you likely have a friend, family member, or colleague whose life has been disrupted by opioid abuse.
On November 10, 2025 the FDA announced a change to the labeling for menopausal hormone therapy (MHT). This was big news, and it has major ramifications for our patients.
We first started talking about the COVID-19 vaccine five years ago. And somehow, here we are—still talking about it. Still answering patient questions, still sorting through the latest data, and still trying to find the right words when the topic comes up in the exam room.
The population is aging fast, and clinicians are feeling the impact. By 2030, 1 in 5 Americans will be over 65, and older adults already represent the highest healthcare utilization of any age group. Yet fewer than 45% of medical schools have a required geriatrics rotation, leaving most of us to piece together our knowledge on the fly.
The nurse practitioner (NP) profession can trace its roots back to a pediatric clinic in Colorado. In 1965, the first NP program was founded by Dr. Loretta Ford, a public health nurse, and Dr. Henry Silver, a pediatrician. This was in response to an expansion of Medicare and Medicaid that left many at-risk populations without adequate access to primary care, particularly in the pediatric population. Two years later, Boston...
November is here, and with it comes the annual parade of sniffles, fevers, and worried parents in our exam rooms. But this year, the viral season feels especially layered. We’re not just worried about bracing for influenza and RSV— we’re also navigating a new chapter in COVID vaccination, including a notable shift in pediatric recommendations from the American Academy of Pediatrics (AAP).